Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Regenxbio Inc (RGNX)

Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
REGENXBIO to Participate in Upcoming Investor Conferences PR Newswire - Mon May 18, 3:05PM CDT

ROCKVILLE, Md. , May 18, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences:

RGNX : 8.26 (+4.56%)
RGNX: The Duchenne Data That Could Redefine Everything Investors Thought They Knew Barchart - Fri May 15, 4:02PM CDT

Barchart Research What to Expect from RGNX Earnings RGNX Generated May 15, 2026 Current Price $5.72 EPS Estimate $$0.21 Consensus Rating Strong Buy Average Move 4.28% RGNX: The Duchenne Data That Could...

RGNX : 8.26 (+4.56%)
Regenxbio: Q1 Earnings Snapshot AP - Thu May 14, 6:18AM CDT

Regenxbio: Q1 Earnings Snapshot

RGNX : 8.26 (+4.56%)
REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights PR Newswire - Thu May 14, 6:10AM CDT

ROCKVILLE, Md. , May 14, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today reported financial results and operational highlights for the first quarter ended March 31, 2026.

RGNX : 8.26 (+4.56%)
REGENXBIO Announces Positive Topline Results from Pivotal Phase III AFFINITY DUCHENNE® Study of RGX-202 PR Newswire - Thu May 14, 6:00AM CDT

ROCKVILLE, Md. , May 14, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) announced positive topline and interim functional data from the pivotal Phase III portion of the Phase I/II/III AFFINITY...

RGNX : 8.26 (+4.56%)
REGENXBIO Duchenne Pivotal Data Lands Before Markets Adjust to Last Quarter's Miss Barchart - Sun May 10, 4:00PM CDT

Barchart Research What to Expect from RGNX Earnings RGNX Generated May 8, 2026 Current Price $10.55 EPS Estimate $$-1.36 Consensus Rating Strong Buy Average Move 4.28% REGENXBIO Duchenne Pivotal Data Lands...

RGNX : 8.26 (+4.56%)
REGENXBIO Duchenne Pivotal Data Lands Before Markets Adjust to Last Quarter's Miss Barchart - Sat May 9, 4:01PM CDT

Barchart Research What to Expect from RGNX Earnings RGNX Generated May 8, 2026 Current Price $10.55 EPS Estimate $$-1.36 Consensus Rating Strong Buy Average Move 4.28% REGENXBIO Duchenne Pivotal Data Lands...

RGNX : 8.26 (+4.56%)
REGENXBIO Duchenne Pivotal Data Lands Before Markets Adjust to Last Quarter's Miss Barchart - Fri May 8, 4:11PM CDT

Barchart Research What to Expect from RGNX Earnings RGNX Generated May 8, 2026 Current Price $10.55 EPS Estimate $$-1.36 Consensus Rating Strong Buy Average Move 4.28% REGENXBIO Duchenne Pivotal Data Lands...

RGNX : 8.26 (+4.56%)
REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting PR Newswire - Thu May 7, 6:05AM CDT

ROCKVILLE, Md. , May 7, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the 2026 American Society of Gene & Cell Therapy Annual Meeting ("ASGCT 2026") taking...

RGNX : 8.26 (+4.56%)
REGENXBIO to Host Webcast on May 14 to Discuss Topline Results from Pivotal Trial of RGX-202 for Duchenne Muscular Dystrophy PR Newswire - Wed May 6, 6:05AM CDT

-- Company will also report first quarter 2026 financial results and operational highlights --

RGNX : 8.26 (+4.56%)

Barchart Exclusives

FOX Stock Is Attractive With Roku Deal Likely to Create Long-Term Value Barchart - 20 minutes ago
Investors may want to play FOX stock after news of its $22 billion acquisition deal. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.